Julian Gutzeit, Martin Weiß, Thomas Bahmer, Wolfgang Lieb, Stefan Schreiber, J Janne Vehreschild, Carolin Nürnberger, Sina M Pütz, Ekaterina Heim, Anne-Kathrin Ruß, Astrid Dempfle, Michael Krawczak, Susanne Poick, Anna Schäfer, Caroline Morbach, Clara Lehmann, M Cristina Polidori, Jens-Peter Reese, Thomas Zoller, Lilian Krist, Jan Heyckendorf, Lennart Michel Reinke, Jürgen Deckert, Grit Hein
{"title":"Long-term trends in Post-COVID severity: a machine learning analysis from the POP/COVIDOM cohort of the German NAPKON Cohort Network.","authors":"Julian Gutzeit, Martin Weiß, Thomas Bahmer, Wolfgang Lieb, Stefan Schreiber, J Janne Vehreschild, Carolin Nürnberger, Sina M Pütz, Ekaterina Heim, Anne-Kathrin Ruß, Astrid Dempfle, Michael Krawczak, Susanne Poick, Anna Schäfer, Caroline Morbach, Clara Lehmann, M Cristina Polidori, Jens-Peter Reese, Thomas Zoller, Lilian Krist, Jan Heyckendorf, Lennart Michel Reinke, Jürgen Deckert, Grit Hein","doi":"10.1016/j.eclinm.2026.103822","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Post-COVID syndrome (PCS) affects many survivors with varying symptom profiles driven by acute disease severity (PCS-S) or individual resilience (PCS-R). While cross-sectional studies have identified risk factors and gender differences, long-term trajectories remain unclear. This study investigates the stability and progression of PCS-S and PCS-R scores after 9, 24 and 36 months from initial diagnosis, identifying key predictive factors stratified by gender.</p><p><strong>Methods: </strong>We analyzed data from 1526 participants of the German National Pandemic Cohort Network (NAPKON), modeling symptom-based PCS-score trajectories over time with linear mixed-effects models. Data were split into training (n = 944), test (n = 233), and two-site external validation (n = 349) sets. Gender-stratified elastic-net regression used nine-month clinical and psychosocial measures to predict PCS scores at 24 and 36 months. All data were collected between November 2020 and February 2024. The study is registered on ClinicalTrials.gov (NCT04679584) and in the German Registry for Clinical Studies (DRKS00023742).</p><p><strong>Findings: </strong>PCS-S and PCS-R scores showed small but significant declines between 9 and 36 months (β = -0.054 and -0.065, respectively; p < 0.001), indicating persistent symptom burden despite gradual improvement. Predictive models explained 16.7-52.6% of variance in later PCS severity. Fatigue after 9 months and age predicted later PCS-S; quality of life and depression added predictive value in females. Fatigue and sleep issues predicted PCS-R, with living/employment status relevant in females and cognitive deficits in males.</p><p><strong>Interpretation: </strong>The severity of PCS subtype manifest after 9 months remains relatively stable over time, with distinct gender-specific predictors shaping symptom progression. Tailored interventions are essential for long-term management of PCS pathways.</p><p><strong>Funding: </strong>The COVIDOM study is funded by the Network University Medicine as part of the NAPKON.</p>","PeriodicalId":11393,"journal":{"name":"EClinicalMedicine","volume":"93 ","pages":"103822"},"PeriodicalIF":10.0000,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12995463/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EClinicalMedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.eclinm.2026.103822","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Post-COVID syndrome (PCS) affects many survivors with varying symptom profiles driven by acute disease severity (PCS-S) or individual resilience (PCS-R). While cross-sectional studies have identified risk factors and gender differences, long-term trajectories remain unclear. This study investigates the stability and progression of PCS-S and PCS-R scores after 9, 24 and 36 months from initial diagnosis, identifying key predictive factors stratified by gender.
Methods: We analyzed data from 1526 participants of the German National Pandemic Cohort Network (NAPKON), modeling symptom-based PCS-score trajectories over time with linear mixed-effects models. Data were split into training (n = 944), test (n = 233), and two-site external validation (n = 349) sets. Gender-stratified elastic-net regression used nine-month clinical and psychosocial measures to predict PCS scores at 24 and 36 months. All data were collected between November 2020 and February 2024. The study is registered on ClinicalTrials.gov (NCT04679584) and in the German Registry for Clinical Studies (DRKS00023742).
Findings: PCS-S and PCS-R scores showed small but significant declines between 9 and 36 months (β = -0.054 and -0.065, respectively; p < 0.001), indicating persistent symptom burden despite gradual improvement. Predictive models explained 16.7-52.6% of variance in later PCS severity. Fatigue after 9 months and age predicted later PCS-S; quality of life and depression added predictive value in females. Fatigue and sleep issues predicted PCS-R, with living/employment status relevant in females and cognitive deficits in males.
Interpretation: The severity of PCS subtype manifest after 9 months remains relatively stable over time, with distinct gender-specific predictors shaping symptom progression. Tailored interventions are essential for long-term management of PCS pathways.
Funding: The COVIDOM study is funded by the Network University Medicine as part of the NAPKON.
期刊介绍:
eClinicalMedicine is a gold open-access clinical journal designed to support frontline health professionals in addressing the complex and rapid health transitions affecting societies globally. The journal aims to assist practitioners in overcoming healthcare challenges across diverse communities, spanning diagnosis, treatment, prevention, and health promotion. Integrating disciplines from various specialties and life stages, it seeks to enhance health systems as fundamental institutions within societies. With a forward-thinking approach, eClinicalMedicine aims to redefine the future of healthcare.